Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Mass Spectrometry Reviews|April 24, 2025
Mass Spectrometry-Based Proteomics for Next-Generation Precision OncologyKuen-Tyng Lin, Gul Muneer, Pei-Rong Huang, et al.
Journal of Biomedical Science|September 1, 2005
Epigenetic activation of alpha4, beta2 and beta6 integrins involved in cell migration in trichostatin A-treated Hep3B cellsKuen-Tyng Lin, Shiou-Hwei Yeh, Ding-Shinn Chen, et al.
Neoplasia (New York, N.Y.)|August 18, 2011
Identification of oncogenic point mutations and hyperphosphorylation of anaplastic lymphoma kinase in lung cancerYi-Wei Wang, Pang-Hsien Tu, Kuen-Tyng Lin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 20, 2012
HDAC inhibitors augmented cell migration and metastasis through induction of PKCs leading to identification of low toxicity modalities for combination cancer therapyKuen-Tyng Lin, Yi-Wei Wang, Chiung-Tong Chen, et al.
Computational and Structural Biotechnology Journal|May 2, 2022
Prognostic comparative genes predict targets for sorafenib combination therapies in hepatocellular carcinomaChun-Ming Ho, Kuen-Tyng Lin, Roger Shen, et al.
Hepatology (Baltimore, Md.)|March 6, 2013
Overexpressed-eIF3I interacted and activated oncogenic Akt1 is a theranostic target in human hepatocellular carcinomaYi-Wei Wang, Kuen-Tyng Lin, Shu-Chuan Chen, et al.
Oncogene|March 22, 2018
Mutant KRAS promotes liver metastasis of colorectal cancer, in part, by upregulating the MEK-Sp1-DNMT1-miR-137-YB-1-IGF-IR signaling pathwayPo-Chen Chu, Peng-Chan Lin, Hsing-Yu Wu, et al.
Hepatology (Baltimore, Md.)|August 28, 2010
Overlapping high-resolution copy number alterations in cancer genomes identified putative cancer genes in hepatocellular carcinomaChian-Feng Chen, En-Chi Hsu, Kuen-Tyng Lin, et al.
Molecular Cancer Research : MCR|May 9, 2022
Phosphoproteomics Reveals the Role of Constitutive KAP1 Phosphorylation by B-cell Receptor Signaling in Chronic Lymphocytic LeukemiaJung-Lin Wu, Hsin-Yi Wu, Shang-Ju Wu, et al.
Molecular Cancer|June 4, 2026
Navigating luminal heterogeneity: etiology-based proteogenomic subtyping for targeted treatment strategies in breast cancerYa-Hsuan Chang, Yi-Ju Chen, Zhi-Jie Hong, et al.
Pageof 2